Printer Friendly
The Free Library
14,716,803 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Xcyte Therapies, Inc. Announces Quarterly Dividend for 6% Convertible Exchangeable Preferred Stock.


SEATTLE Seattle (sēăt`əl), city (1990 pop. 516,259), seat of King co., W Wash., built on seven hills, between Elliott Bay of Puget Sound and Lake Washington; inc. 1869.  -- Xcyte Therapies, Inc. ("Xcyte," the "Company") (Nasdaq:XCYT) (Nasdaq:XCYTP) announced today that the Company's Board of Directors has declared a quarterly dividend in the amount of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock Convertible exchangeable preferred stock

Convertible preferred stock that may be exchanged, at the issuer's option, into convertible bonds that have the same conversion features as the convertible preferred stock.
 (the "Preferred Stock Stock shares that have preferential rights to dividends or to amounts distributable on liquidation, or to both, ahead of common shareholders.

Preferred stock is given preference over common stock. Holders of preferred stock receive dividends at a fixed annual rate.
") in accordance Accordance is Bible Study Software for Macintosh developed by OakTree Software, Inc.[]

As well as a standalone program, it is the base software packaged by Zondervan in their Bible Study suites for Macintosh.
 with the terms thereof. Xcyte issued 2,990,000 shares of the Preferred Stock in November 2004. As of October 4, 2005, approximately 943,000 shares of the Preferred Stock have been converted to the Company's common stock. The dividend on the Preferred Stock will be paid on November 1, 2005, to the holders of record as of the close of business on October 21, 2005.

Xcyte(R) and Xcyte Therapies(TM) are trademarks of Xcyte Therapies, Inc.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Oct 5, 2005
Words:122
Previous Article:Hypertronics Announces a New Level of Performance for MIL-DTL-38999 Connectors; New HyperRel(TM) connectors offer immunity to shock and vibration,...
Next Article:SunGard's AddVantage Offers Automated Security Master Set Up Capability with New FT Interactive Data XML Web-Based Process.
Topics:



Related Articles
American Equity sets $67.8 million stock issue. (American Equity Trust Inc.)
Xcyte Therapies, Inc. Announces Pricing for Public Offering of 6% Convertible Exchangeable Preferred Stock.
Xcyte Therapies, Inc. Announces Exercise of Over-Allotment Option and Closing of Public Offering of 6% Convertible Exchangeable Preferred Stock.
Xcyte Therapies, Inc. Announces Third Quarter 2004 Financial Results.
Xcyte Therapies, Inc. Announces Quarterly Dividend For 6% Convertible Exchangeable Preferred Stock.
Xcyte Therapies, Inc. Announces Full-Year and Fourth-Quarter 2004 Financial Results.
Xcyte Therapies, Inc. Announces Quarterly Dividend for 6% Convertible Exchangeable Preferred Stock.
Xcyte Therapies, Inc. Announces Quarterly Dividend for 6% Convertible Exchangeable Preferred Stock.
Xcyte Therapies, Inc. Announces Quarterly Dividend For 6% Convertible Exchangeable Preferred Stock.
Xcyte Therapies, Inc. Announces Full-Year and Fourth Quarter 2005 Financial Results.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles